Arcus Biosciences

Developer of immune-focused cancer therapies targeting the ATP-adenosine pathway

placeHayward, California, United States calendar_todayFounded 2015 groups577 employees language arcusbio.com

Registered entities

Investor mix

20 investors on record; lead investors include Google Ventures, Droia Ventures; 4 have since exited.

Investor typeCountShare
Venture capital1050%
Private equity420%
Bank & private debt15%
Other / undisclosed525%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

8 Oct 2025 · Senior Director, Regulatory Affairs (Office or Remote) · Hayward

17 Jan 2025 · Senior Clinical Data Manager · Hartford

Based on job postings tracked across public sources.

Coming soon